Michel Vounatsos
Also Known As Vounatsos
Education
- MBA - HEC Paris
- CSCT, Medicine - Université de Bordeaux
Overview
Michel Vounatsos is a Chief Executive Officer of Biogen(BIIB)and a member of its Board of Directors since January 2017. Joined the company in 2016 as Executive Vice-President, Chief Commercial Officer. Biogen is pursuing its strategy as a leader in neuroscience as well as adjacent therapeutic areas, underpinned by the belief that neurological diseases and treatment strategies are interconnected. Prior to joining Biogen, had a 20-year career at Merck and has additionally held management positions at Ciba-Geigy
Career
- Biogen - CEO